BioSpace News Archive

Data platform and systematic measurement methodology provides Excelera member health systems powerful insights into disease state-specific adherence data not available to non-member health systems

Baylis Medical announced key activities that will be featured at Transcatheter Cardiovascular Therapeutics 2019, the Cardiovascular Research Foundation’s 31st annual conference and premier interventional cardiovascular medicine educational meeting, in San Francisco, CA from September 25-29.

Ginkgo accelerates widespread adoption of synthetic biology, including new partnerships with startup accelerators Y Combinator and Petri

Viseon, Inc. announced US FDA clearance and initial clinical use of their Voyant System, integrating minimally invasive surgical access with real time high definition imaging technology for more efficient procedural workflow, which enhances a clinician’s intraoperative visualization, providing a more accurate, precise and unimpeded view of the operative field.

A new report from the Canadian Institute for Health Information (CIHI) shows that cannabis and alcohol were the most common substances associated with hospital stays among this age group in 2017–2018.

Takeda Pharmaceutical Company Limited announced that it has been named in the 2019 Dow Jones Sustainability World Index, achieving more than double the average overall industry score.

The SanBio Group announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) Designation for SB623 cell therapy for the treatment of chronic neurological motor deficits secondary to traumatic brain injury (TBI).

AveXis announced that new interim data from the Phase 3 SPR1NT trial in pre-symptomatic patients as well as interim data from the ongoing Phase 3 STR1VE clinical program for Zolgensma®

Medical Optometry America (MOA) is excited to announce that it has signed an agreement with Associates in Eyecare – Optometrists (AIE) under which AIE will become the nation’s first group of independent optometric practices to adopt the MOA Brand.

Stakeholders meet at Patient Safety Movement Foundation Midyear Planning meeting to plan for ZERO preventable deaths in hospitals